Insider Buy/Sell Details for the Healthcare Sector — May 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1601)
Entrada Therapeutics, Inc. (TRDA)
Zeiher Bernhardt G — Director
Shares
5,000
Price
$5.86
Total Value
$29.32K
Shares Held After
5,000
% of Holdings
100.0%
ClearPoint Neuro, Inc. (CLPT)
FALLON LYNNETTE C — Director
Shares
5,091
Price
$11.14
Total Value
$56.71K
Shares Held After
48,227
% of Holdings
9.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
200
Price
$577.26
Total Value
$115.45K
Shares Held After
40,513
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
245
Price
$574.08
Total Value
$140.65K
Shares Held After
40,713
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
195
Price
$573.00
Total Value
$111.73K
Shares Held After
40,958
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
376
Price
$571.41
Total Value
$214.85K
Shares Held After
41,153
% of Holdings
0.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
552
Price
$570.38
Total Value
$314.85K
Shares Held After
41,529
% of Holdings
1.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
660
Price
$569.30
Total Value
$375.74K
Shares Held After
42,081
% of Holdings
1.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
412
Price
$568.34
Total Value
$234.15K
Shares Held After
42,741
% of Holdings
1.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
280
Price
$566.89
Total Value
$158.73K
Shares Held After
43,153
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
840
Price
$565.95
Total Value
$475.39K
Shares Held After
43,433
% of Holdings
1.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,280
Price
$564.81
Total Value
$722.95K
Shares Held After
44,273
% of Holdings
2.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,949
Price
$563.97
Total Value
$1.10M
Shares Held After
45,553
% of Holdings
4.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,071
Price
$562.94
Total Value
$1.17M
Shares Held After
47,502
% of Holdings
4.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
440
Price
$562.01
Total Value
$247.28K
Shares Held After
49,573
% of Holdings
0.9%
Precipio, Inc. (PRPO)
SANDBERG RICHARD A — Director
Shares
2,034
Price
$24.89
Total Value
$50.63K
Shares Held After
8,142
% of Holdings
20.0%
Precipio, Inc. (PRPO)
SANDBERG RICHARD A — Director
Shares
500
Price
$25.00
Total Value
$12.50K
Shares Held After
3,900
% of Holdings
11.4%
FATE THERAPEUTICS INC (FATE)
TAHL CINDY — Chief Legal and Compliance Officer
Shares
25,590
Price
$1.88
Total Value
$48.08K
Shares Held After
628,155
% of Holdings
3.9%
FATE THERAPEUTICS INC (FATE)
Valamehr Bahram — Director
Shares
28,946
Price
$1.88
Total Value
$54.48K
Shares Held After
635,762
% of Holdings
4.4%
Immunovant, Inc. (IMVT)
Pande Atul — Director
Shares
6,000
Price
$32.00
Total Value
$192.00K
Shares Held After
116,731
% of Holdings
4.9%
Liquidia Corp (LQDA)
JEFFS ROGER — Director
Shares
25,000
Price
$61.30
Total Value
$1.53M
Shares Held After
1,123,095
% of Holdings
2.2%
Werewolf Therapeutics, Inc. (HOWL)
EVNIN LUKE — Director
Shares
85,895
Price
$0.43
Total Value
$36.93K
Shares Held After
955,447
% of Holdings
8.2%
INTUITIVE SURGICAL INC (ISRG)
Brosius Mark — EVP & Chief Mfg and Supply Cha
Shares
18
Price
$440.38
Total Value
$7.93K
Shares Held After
1,559
% of Holdings
1.1%
MARIMED INC. (MRMD)
Levine Jon R — Director
Shares
40,000
Price
$0.07
Total Value
$3.00K
Shares Held After
21,247,986
% of Holdings
0.2%
HEALTHSTREAM INC (HSTM)
O'Hara Kevin P — Executive Vice President
Shares
3,000
Price
$24.08
Total Value
$72.23K
Shares Held After
20,982
% of Holdings
12.5%
AVITA Medical, Inc. (RCEL)
O'Toole David D — CFO
Shares
2,000
Price
$4.26
Total Value
$8.52K
Shares Held After
145,927
% of Holdings
1.4%
Serina Therapeutics, Inc. (SER)
Marshall Richard Peter — Director
Shares
12,183
Price
$1.65
Total Value
$20.10K
Shares Held After
12,183
% of Holdings
100.0%
BIOLIFE SOLUTIONS INC (BLFS)
Casdin Partners Master Fund, L.P. — 10% Owner
Shares
300,000
Price
$22.65
Total Value
$6.79M
Shares Held After
5,657,165
% of Holdings
5.0%
NEKTAR THERAPEUTICS (NKTR)
Zalevsky Jonathan — Chief R&D Officer
Shares
199
Price
$65.51
Total Value
$13.04K
Shares Held After
20,975
% of Holdings
0.9%
BioCardia, Inc. (BCDA)
Altman Peter — Director
Shares
200
Price
$0.95
Total Value
$190.00
Shares Held After
291,766
% of Holdings
0.1%
NEKTAR THERAPEUTICS (NKTR)
ROBIN HOWARD W — Director
Shares
444
Price
$65.51
Total Value
$29.09K
Shares Held After
75,045
% of Holdings
0.6%
CVS HEALTH Corp (CVS)
ROBBINS LARRY — Director
Shares
151
Price
$95.18
Total Value
$14.37K
Shares Held After
6,213,261
% of Holdings
0.0%
CVS HEALTH Corp (CVS)
ROBBINS LARRY — Director
Shares
1,983,387
Price
$94.45
Total Value
$187.33M
Shares Held After
6,213,412
% of Holdings
24.2%
NEUROCRINE BIOSCIENCES INC (NBIX)
GORMAN KEVIN CHARLES — Director
Shares
245,088
Price
$154.33
Total Value
$37.82M
Shares Held After
511,293
% of Holdings
32.4%
InspireMD, Inc. (NSPR)
Gleason Shane Thomas — Chief Commercial Officer
Shares
22,778
Price
$1.01
Total Value
$23.01K
Shares Held After
1,053,882
% of Holdings
2.1%
BOSTON SCIENTIFIC CORP (BSX)
Habiger David C — Director
Shares
2,200
Price
$56.95
Total Value
$125.28K
Shares Held After
11,628
% of Holdings
18.9%
Tempus AI, Inc. (TEM)
Polovin Andrew — EVP, Chief Legal Officer
Shares
8,703
Price
$44.07
Total Value
$383.54K
Shares Held After
128,215
% of Holdings
6.4%
Warby Parker Inc. (WRBY)
Blumenthal Neil Harris — Director
Shares
63,040
Price
$30.03
Total Value
$1.89M
Shares Held After
50,165
% of Holdings
55.7%
Tempus AI, Inc. (TEM)
Bartolucci Ryan M — Chief Accounting Officer
Shares
4,116
Price
$44.07
Total Value
$181.39K
Shares Held After
74,041
% of Holdings
5.3%
Tempus AI, Inc. (TEM)
Fukushima Ryan — CEO, Data
Shares
13,550
Price
$44.07
Total Value
$597.15K
Shares Held After
603,558
% of Holdings
2.2%
Tempus AI, Inc. (TEM)
LEFKOFSKY ERIC P — Director
Shares
22,335
Price
$44.07
Total Value
$984.30K
Shares Held After
2,230,721
% of Holdings
1.0%
Tempus AI, Inc. (TEM)
Schoenherr Thomas Edward — CEO, Diagnostics
Shares
1,580
Price
$44.07
Total Value
$69.63K
Shares Held After
107,029
% of Holdings
1.5%
InMed Pharmaceuticals Inc. (INM)
ADAR1 Capital Management, LLC — 10% Owner
Shares
200,000
Price
$1.50
Total Value
$299.80K
Shares Held After
800,000
% of Holdings
25.0%
InMed Pharmaceuticals Inc. (INM)
ADAR1 Capital Management, LLC — 10% Owner
Shares
200,000
Price
$1.56
Total Value
$312.08K
Shares Held After
600,000
% of Holdings
33.3%
InMed Pharmaceuticals Inc. (INM)
ADAR1 Capital Management, LLC — 10% Owner
Shares
68,551
Price
$1.60
Total Value
$109.67K
Shares Held After
400,000
% of Holdings
17.1%
Tempus AI, Inc. (TEM)
Rogers James William — Chief Financial Officer
Shares
10,853
Price
$44.07
Total Value
$478.29K
Shares Held After
126,395
% of Holdings
7.9%
Progyny, Inc. (PGNY)
Cummings Melissa B — Chief Operating Officer
Shares
9,578
Price
$25.00
Total Value
$239.45K
Shares Held After
73,371
% of Holdings
11.5%
Lumexa Imaging Holdings, Inc. (LMRI)
BRODNAX BRETT — Director
Shares
35,000
Price
$7.25
Total Value
$253.75K
Shares Held After
62,027
% of Holdings
56.4%
Addus HomeCare Corp (ADUS)
Lopez Esteban — Director
Shares
250
Price
$93.00
Total Value
$23.25K
Shares Held After
3,450
% of Holdings
6.8%
INCYTE CORP (INCY)
Clancy Paul J — Director
Shares
15,000
Price
$94.93
Total Value
$1.42M
Shares Held After
23,741
% of Holdings
38.7%
Showing 151–200 of 1601 transactions (page 4 of 33)